natgillin/translations-raw huggingface dataset:
How has Pramipexole Accord been studied? 
Kako je bilo zdravilo Pramipexole Accord raziskano?
How is Pramipexole Accord used? 
Kako se zdravilo Pramipexole Accord uporablja?
20 mg/ml Oral drops, solution 
20 mg/ml Peroralne kapljice, raztopina
15 ml 
Steklenica (steklo) 15 ml
This summary was last updated on 16 July 2012. 
Povzetek je bil nazadnje posodobljen 16. 07. 2012.
1 L. interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000), L interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001), L. interrogans serogroup Australis serovar Bartislava (strain As-05-073), L. kirscheneri serogrop Grippotyphosa serovar Dadas (strain Gr-01-005)). 
1 L. interrogans serološka skupina Canicola serovar Portland-vere (sev Ca-12-000), L interrogans serološka skupina Icterohaemorrhagiae serovar Copenhageni (sev Ic-02-001), L. interrogans serološka skupina Australis serovar Bratislava (sev As-05-073), L. kirscheneri serološka skupina Grippotyphosa serovar Dadas (sev Gr-01-005)).
The company has presented data from both laboratory and field studies to establish the safety and effectiveness of the vaccine, including how long it took for the dogs to be fully protected and how long the vaccine could provide protection. 
Družba je predstavila podatke iz laboratorijskih in terenskih študij, s katerimi je določila varnost in učinkovitost cepiva, vključno s podatkom, kako dolgo traja, da je pes popolnoma zaščiten ter kako dolgo cepivo daje zaščito.
An occasional temporary, acute (short-term) hypersensitivity (allergic) reaction may occur. 
Včasih se lahko pojavi prehodna akutna (kratkotrajna) preobčutljivostna (alergijska) reakcija.
The first injection can be given from six to nine weeks of age and the second four weeks later. 
Prva injekcija se da psu med šestim in devetim tednom starosti, druga pa štiri tedne kasneje.
The main infection source is from urine or urine-contaminated water or soil. 
Glavni vir okužbe je urin ali z okuženim urinom onesnažena tla ali voda.
It contains four inactivated (killed) strains of Leptospira bacteria.1. 
Vsebuje 4 neaktivirane (uničene) seve bakterije Leptospira.1
Leptospirosis disease in dogs results in bleeding, hepatitis (infection of the liver) and jaundice (yellowing of the skin and eyes) or nephritis (kidney infection). 
Leptospiroza je bolezen pri psih, ki povzroča krvavenje, hepatitis (okužbo jeter), zlatenico (porumenitev kože in oči) ali nefritis (okužbo ledvic).
In future if the animals are exposed to the bacteria the immune system will be able to respond more quickly. 
Ob ponovni izpostavitvi bakteriji v prihodnje se bo imunski sistem živali tako hitreje odzval.
When puppies are known to have high levels of maternally derived antibodies (special type of proteins, received from the mother in the milk, that help the body to fight infection), it is recommended that the first vaccination is given at 
Kadar je znano, da imajo mladiči visoko raven maternalno pridobljenih protiteles (posebna vrsta beljakovin, ki jih prejmejo z materinim mlekom in ki pomagajo pri boju z okužbo), je prvo cepljenje priporočeno pri starosti devet tednov.
A small, temporary swelling may occur at the injection site, which will either disappear or reduce in size within two weeks after vaccination. 
Na mestu injiciranja se lahko pojavi majhna prehodna oteklina, ki bodisi izgine ali se znatno zmanjša v dveh tednih po cepljenju.
The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Nobivac L4 exceed the risks and recommended that it be given a marketing authorisation. 
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je zaključil, da so koristi zdravila Nobivac L4 večje od tveganj, in priporočil, da se zanj odobri dovoljenja za promet.
The European Commission granted a marketing authorisation valid throughout the European Union, for Nobivac L4 on 16 July 2012. 
Evropska komisija je dovoljenje za promet z zdravilom Nobivac L4, veljavno po vsej Evropski uniji, odobrila dne 16. 07. 2012.
A mild and temporary increase in body temperature ( 1°C) may occur for a few days after vaccination, with some puppies showing less activity and/or a reduced appetite. 
Za nekaj dni po cepljenju se lahko rahlo in prehodno poveča telesna temperatura ( 1°C), zaradi česar so lahko nekateri mladiči manj aktivni in/ali imajo zmanjšan tek.
Vaccines work by ‘teaching' the immune system (the body's natural defences) how to defend itself against a disease. 
Ta delujejo tako, da imunski sistem (naravni obrambni mehanizem telesa) „naučijo“, kako naj se brani pred boleznijo.
Leptospira vaccine 
Cepivo proti Leptospiri
Nobivac L4 is used to vaccinate dogs from six weeks of age to reduce the risk of developing an infection with certain Leptospira strains. 
Cepivo Nobivac L4 se uporablja za cepljenje psov od 6 tedna starosti za zmanjšanje tveganja za razvoj okužbe z nekaterimi sevi bakterije Leptospira.
The benefit/risk balance can be found in the scientific discussion module of this EPAR. 
Za razmerje med koristmi in tveganji glejte modul o znanstveni razpravi tega evropskega javnega poročila o oceni zdravila (EPAR).
Nobivac L4 is a vaccine available as a suspension for injection. 
Nobivac L4 je cepivo, ki je na voljo kot suspenzija za injiciranje.
Nobivac L4 is a vaccine. 
Zdravilo Nobivac L4 je cepivo.
The vaccine also reduces the excretion (shedding) of the virus into the urine by the infected dogs, thereby reducing the risk of transmission. 
Cepivo pri okuženih psih zmanjša izločanje virusa v urin in tako zmanjšuje tveganje prenosa.
What benefit has Nobivac L4 shown during the studies? 
Kakšne koristi je zdravilo Nobivac L4 izkazalo med študijami?
What is the risk associated with Nobivac L4? 
Kakšna tveganja so povezana z zdravilom Nobivac L4?
When Nobivac L4 is given to dogs, the immune system recognises the bacteria contained in the vaccine as ‘foreign' and makes defences against them. 
Ko pes prejme cepivo, imunski sistem prepozna bakterijo v cepivu kot „tujek“ in proti njej razvije protitelesa.
A single ‘booster' injection should be given every year to maintain the vaccine's effect. 
Za vzdrževanje učinka cepiva je treba nato vsako leto psu injicirati poživitveni odmerek.
Other information about Nobivac L4: 
Druge informacije o zdravilu Nobivac L4:
Why has Nobivac L4 been approved? 
Zakaj je bilo zdravilo Nobivac L4 odobreno?
What is Nobivac L4 used for? 
Za kaj se zdravilo Nobivac L4 uporablja?
How has Nobivac L4 been studied? 
Kako je bilo zdravilo Nobivac L4 raziskano?
What is Nobivac L4? 
Kaj je zdravilo Nobivac L4?
How does Nobivac L4 work? 
Kako zdravilo Nobivac L4 deluje?
Content (concentration) 
<Vsebina (koncentracija)>
(invented) name Strength Pharmaceutical form 
(Izmišljeno) ime Jakost Farmacevtska oblika
Perforated unit dose thermoformed blisters 
Perforirani enoodmerni termoformirani pretisni omoti
MA (EU)-number 
Številka (EU) dovoljenja za promet
Strength Pharmaceutical Form Route of Administration 
Zaščiteno ime Jakost Farmacevtska oblika
How is Zarzio given and how much should I take? 
Kako se daje zdravilo Zarzio in koliko ga naj vzamem?
Zarzio can be used: 
Zdravilo Zarzio se lahko uporablja:
How long will I have to take Zarzio? 
Kako dolgo moram uporabljati zdravilo Zarzio?
As with all therapeutic proteins, there is a potential for immunogenicity. 
Imunogenost Kot pri vseh terapevtskih beljakovinah obstaja možnost imunogenosti.
Period of Study 
Publikacija Obdobje študije
In order to improve the traceability of granulocyte-colony stimulating factors (G-CSFs), the trade name of the administered product should be clearly recorded in the patient file. 
Za izboljšanje sledljivosti granulocitne kolonije spodbujajočih faktorjev (G-CSFs) mora biti dajanje zdravila Zarzio jasno zabeležno v zdravstveni kartoteki bolnika.
Inject the Zarzio solution as you have been shown by your doctor. 
Raztopino zdravila Zarzio injicirajte tako, kot vam je pokazal zdravnik.
This section contains information on how to give yourself an injection of Zarzio. 
To poglavje vsebuje navodila za to, kako morate sami sebi dajati injekcije zdravila Zarzio.
Other medicines and Zarzio 
Druga zdravila in zdravilo Zarzio
Zarzio is usually given as a daily injection into the tissue just under the skin (known as a subcutaneous injection). 
Zdravilo Zarzio se običajno daje kot vsakodnevna injekcija v tkivo tik pod kožo (kar se imenuje podkožna injekcija).
If you forget to use Zarzio 
Če ste pozabili uporabiti zdravilo Zarzio
Detailed information on this medicine is available on the European Medicines Agency (EMA) web site: http://www.ema.europa.eu. 
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila: http://www.ema.europa.eu.
Contents of the pack and other information What Zarzio contains 
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Zarzio
Take special care with other products that stimulate white blood cells. 
Bodite posebno pozorni pri uporabi drugih zdravil, ki spodbujajo bele krvne celice
A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Zarzio therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman. 
Odločiti se je treba med prenehanjem dojenja in prenehanjem/prekinitvijo zdravljenja z zdravilom Zarzio, pri čemer je treba pretehtati prednosti dojenja za otroka in prednosti zdravljenja za mater.
Zarzio is provided with or without a needle safety guard and you will be shown how to use this by your doctor or nurse. 
Zdravilo Zarzio je opremljeno z zaščito za iglo ali pa je brez nje, vaš zdravnik ali medicinska sestra pa vam bosta pokazala, kako to uporabljati.
Randomised, double-blind, single and multiple dose, crossover studies in 204 healthy volunteers showed that the pharmacokinetic profile of Zarzio was comparable to that of the reference product after subcutaneous and intravenous administration. 
Randomizirana, dvojno slepa, po enkratnem in večkratnem odmerku, navzkrižna študija na 204 zdravih prostovoljcih kaže, da je farmakokinetični profil zdravila Zarzio primerljiv s farmakokinetičnim profilom referenčnega zdravila po subkutani in intravenski uporabi.
Following subcutaneous administration of recommended doses, serum concentrations were maintained above 10 ng/ml for 8 - 16 hours. 
Po subkutanem dajanju priporočenega odmerka, se je serumska koncentracija vzdrževala nad vrednostjo 10 ng/ml 8 - 16 ur.
Risk associated with increased doses of myelosuppressive medicinal products 
Tveganje, povezano z večjimi odmerki mielosupresivnih zdravil
Following induction and consolidation treatment for acute myeloid leukaemia the duration of treatment may be substantially longer (up to 38 days) depending on the type, dose and schedule of cytotoxic chemotherapy used. 
Po indukcijskem in konsolidacijskem zdravljenju akutne mieloične levkemije je zdravljenje lahko bistveno daljše (do 38 dni), odvisno od vrste citotoksične kemoterapije, njenega odmerka in časovnega razporeda.
In view of the possible risk of microbial contamination, Zarzio syringes are for single use only. 
Zaradi možnega tveganja kontaminacije z mikrobi so brizge zdravila Zarzio namenjene le enkratni uporabi.
What Zarzio is and what it is used for What you need to know before you use Zarzio How to use Zarzio 
Kaj je zdravilo Zarzio in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Zarzio Kako uporabljati zdravilo Zarzio
What you need to know before you use Zarzio Do not use Zarzio 
Kaj morate vedeti, preden boste uporabili zdravilo Zarzio Ne uporabljajte zdravila Zarzio
Zarzio is used to treat children who are receiving chemotherapy or who suffer from severe low white blood cell count (neutropenia). 
Zdravilo Zarzio se uporablja za zdravljenje otrok, ki prejemajo kemoterapijo, ali ki imajo zelo nizko število belih krvnih celic (nevtropenija).
Zarzio is a white blood cell growth factor (granulocyte colony stimulating factor) and belongs to a group of proteins called cytokines. 
Zdravilo Zarzio je rastni faktor za bele krvne celice (granulocitne kolonije spodbujajoči faktor) in sodi v skupino beljakovin, imenovanih citokini.
Zarzio containing r-metHuG-CSF (filgrastim) causes marked increases in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes. 
Zdravilo Zarzio, ki vsebuje r-metHuG-CSF (filgrastim), v 24 urah izrazito poveča število nevtrofilcev v periferni krvi; število monocitov pa se ob tem le nekoliko poveča.
You will need to take Zarzio until your white blood cell count is normal. 
Zdravilo Zarzio morate uporabljati, dokler se vaše število belih krvnih celic ne normalizira.
Zarzio is available in packs containing 1, 3, 5 or 10 pre-filled syringes with injection needle and with or without a needle safety guard. 
Zdravilo Zarzio je na razpolago v pakiranjih, ki vsebujejo 1, 3, 5 ali 10 napolnjenih injekcijskih brizg z injekcijsko iglo, z varnostno zaščito za iglo, ali brez te zaščite.
Filgrastim did not affect reproductive performance or fertility in male or female rats (see section 5.3). 
Filgrastim ni vplival na plodnost podganjih samcev in samic (glejte poglavje 5.3).
International Retrospective Study (2006) 
Evropska retrospektivna študija (2004) 1992 - 2002b 1789 Mednarodna retrospektivna študija (2006) 1995 - 2000b 2.110
Zarzio 30 MU/0.5 ml 
Zarzio 30 M e./0,5 ml
If you develop or are likely to develop cancers of the blood, you should not use Zarzio unless instructed by your doctor. 
Če se krvni rak razvije ali če obstaja verjetnost, da se bo razvil, zdravila Zarzio ne smete uporabljati, razen če vam je tako naročil zdravnik.
Your doctor will tell you how much Zarzio you should take. 
Vaš zdravnik vam bo povedal, koliko zdravila Zarzio morate vzeti.
How to use Zarzio 
Kako uporabljati zdravilo Zarzio
What Zarzio is and what it is used for 
Kaj je zdravilo Zarzio in za kaj ga uporabljamo
Zarzio 48 MU/0.5 ml 
Zarzio 48 M e./0,5 ml
Do not administer Zarzio to patients with a history of hypersensitivity to filgrastim or pegfilgrastim. 
Zdravila Zarzio ne dajajte bolnikom s preobčutljivostjo na filgrastim ali pegfilgrastim v anamnezi.
Zarzio has not been tested in pregnant or breast-feeding women. 
Zdravila Zarzio pri nosečnicah ali doječih materah niso preskusili.
- Reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. 
- Skrajšanje trajanja nevtropenije in zmanjšanje pogostnosti pojavljanja febrilne nevtropenije pri bolnikih, zdravljenih z vpeljano citotoksično kemoterapijo zaradi malignih obolenj (z izjemo kronične mieloične levkemije in mielodisplastičnih sindromov) in skrajšanje trajanja nevtropenije pri bolnikih, pri katerih se izvaja mieloablacijsko zdravljenje, ki mu sledi presaditev kostnega mozga, za te bolnike pa se domneva, da so izpostavljeni povečanemu tveganju za pojav dolgotrajne hude nevtropenije.
Intravenous (80 µg/kg/day) administration of filgrastim to rabbits during the period of organogenesis was maternally toxic and increased spontaneous abortion, post-implantation loss, and decreased mean live litter size and foetal weight were observed. 
(80 µg/kg/dan) dajanju filgrastima kuncem v obdobju organogeneze so ugotovili toksične učinke na brejo samico in povečane stopnje spontanega abortusa, postimplantacijske izgube ter zmanjšanja povprečne velikosti legla in mase ploda.
Accidental exposure to freezing temperatures does not adversely affect the stability of Zarzio. 
Naključna izpostavljenost temperaturam v območju zmrzišča nima neugodnega vpliva na stabilnost zdravila Zarzio.
Accidental freezing will not harm Zarzio. 
Nenamerno zamrzovanje ne škoduje zdravilu Zarzio.
You will normally receive your first dose of Zarzio at least 24 hours after your chemotherapy and at least 24 hours after receiving your bone marrow transplant. 
Običajno boste prvi odmerek zdravila Zarzio prejeli vsaj 24 ur po kemoterapiji in vsaj 24 ur po presaditvi kostnega mozga.
1995 - 2000b a Analysis includes studies involving BM transplant during this period; some studies used GM-CSF b Analysis includes patients receiving BM transplant during this period 
a Analiza obsega študije, ki vključujejo presaditve kostnega mozga v tem časovnem obdobju; v nekaterih študijah je bila uporabljena GM-CSF
Zarzio contains sorbitol 
Zdravilo Zarzio vsebuje sorbitol
If you become pregnant during Zarzio treatment, please inform your doctor. 
Če zanosite med zdravljenjem z zdravilom Zarzio, se posvetujte z zdravnikom.
Zarzio stimulates the bone marrow to produce new white cells quickly. 
Zdravilo Zarzio spodbuja kostni mozeg k hitremu proizvajanju novih belih krvnih celic.
Congenital neutropenia 
Prirojena nevtropenija
Filgrastim should be administered daily by subcutaneous injection until the neutrophil count has reached and can be maintained at more than 1.5 x 109/l. 
Prilagoditev odmerka Filgrastim je treba dajati vsak dan kot subkutana injekcija, dokler število nevtrofilcev ne preseže vrednosti 1,5 x 109/l in ga je na tej ravni mogoče vzdrževati.
Please tell your doctor immediately during treatment with Zarzio, if you: - get left upper belly (abdominal) pain, pain below the left rib cage or at the tip of your left shoulder [these may be symptoms of an enlarged spleen (splenomegaly), or possibly rupture of the spleen]. 
Med zdravljenjem z zdravilom Zarzio takoj povejte zdravniku, če: - začutite bolečino v zgornjem levem delu trebuha (abdominalna bolečina), bolečino pod levim delom prsnega koša ali bolečino na vrhu leve rame [to so lahko simptomi povečane vranice
Zarzio is a clear, colourless to slightly yellowish solution for injection or infusion in pre-filled syringe. 
Zdravilo Zarzio je bistra, brezbarvna do rahlo rumenkasta raztopina za injiciranje ali infundiranje v napolnjeni injekcijski brizgi.
Contents of the pack and other information 
Shranjevanje zdravila Zarzio Vsebina pakiranja in dodatne informacije
Zarzio works by encouraging the bone marrow to produce more white blood cells. 
Zdravilo Zarzio deluje tako, da spodbuja kostni mozeg k proizvajanju več belih krvnih celic.
Your doctor will tell you how long you will need to take Zarzio. 
Vaš zdravnik vam bo povedal, kako dolgo boste morali zdravilo Zarzio uporabljati.
In patients treated with myeloablative therapy followed by bone marrow transplantation 
Pri bolnikih, zdravljenih z mieloablacijsko terapijo, ki ji sledi presaditev kostnega mozga Odmerjanje
Solution for injection or infusion in pre-filled syringe. 
Raztopina za injiciranje ali infundiranje v napolnjeni injekcijski brizgi.
Zarzio may have a minor influence on your ability to drive and use machines. 
Zdravilo Zarzio ima lahko blag vpliv na sposobnost upravljanja vozil in strojev.
Zarzio contains no preservative. 
Zdravilo Zarzio ne vsebuje konzervansov.
Zarzio contains sorbitol (E420). 
Zdravilo Zarzio vsebuje sorbitol (E420).
- have sudden signs of allergy such as rash, itching or hives on the skin, swelling of the face, lips, tongue or other parts of the body, shortness of breath, wheezing or trouble breathing as these could be signs of a severe allergic reaction (hypersensitivity). 
- se nenadoma pojavijo znaki alergije, kot so izpuščaj, srbenje ali koprivnica na koži, otekanje obraza, ustnic, jezika ali drugih delov telesa, zasoplost, piskanje v pljučih ali oteženo dihanje,
If required, Zarzio may be diluted in glucose 50 mg/ml (5%) solution. 
Če je potrebno, se zdravilo Zarzio lahko razredči v 5 % (50 mg/ml) raztopini glukoze.
Treatment with filgrastim alone does not preclude thrombocytopenia and anaemia due to myelosuppressive treatments. 
Zdravljenje s filgrastimom samim ne prepreči trombocitopenije in anemije, povzročenih z mielosupresivnimi zdravili.
What Zarzio looks like and contents of the pack 
Izgled zdravila Zarzio in vsebina pakiranja
Zarzio must not be diluted with sodium chloride solution. 
Zdravila Zarzio se ne sme redčiti z raztopinami natrijevega klorida.
Zarzio 30 MU/0.5 ml solution for injection or infusion in pre-filled syringe EU/1/08/495/001 
Zarzio 30 M e./0,5 ml raztopina za injiciranje ali infundiranje v napolnjeni injekcijski brizgi EU/1/08/495/001
Zarzio 48 MU/0.5 ml solution for injection or infusion in pre-filled syringe EU/1/08/495/005 
Zarzio 48 M e./0,5 ml raztopina za injiciranje ali infundiranje v napolnjeni injekcijski brizgi EU/1/08/495/005
It is advisable to wait and see how you feel after taking Zarzio and before driving or operating machinery. 
Pred vožnjo ali upravljanjem s stroji je priporočljivo počakati, da vidite, kako se po uporabi zdravila Zarzio počutite.
Zarzio is one of a group of products that stimulate the production of white blood cells. 
Zdravilo Zarzio sodi v skupino zdravil, ki spodbujajo nastanek belih krvnih celic.
Special precautions in patients with HIV infection 
Posebni previdnostni ukrepi pri bolnikih z okužbo s HIV Število krvnih celic
The recommended dose of filgrastim is 0.5 MU/kg/day (5 μg/kg/day). 
Odmerjanje Priporočeni odmerek filgrastima je 0,5 M e./kg/dan (5 µg/kg/dan).
• unusual hair loss or thinning (alopecia) 
• neobičajno izpadanje ali redčenje las (alopecija) • utrujenost (izčrpanost)
Using the pre-filled syringe with a needle safety guard The needle safety guard covers the needle after injection to prevent needle stick injury. 
Varnostna zaščita za iglo po injiciranju iglo prekrije, da bi tako preprečila poškodbe zaradi vboda z iglo.
Zarzio 48 MU/0.5 ml solution for injection or infusion in pre-filled syringe Each ml of solution contains 96 million units (MU) (equivalent to 960 micrograms [μg]) filgrastim*. 
Zarzio 48 M e./0,5 ml raztopina za injiciranje ali infundiranje v napolnjeni injekcijski brizgi En mililiter raztopine vsebuje 96 milijonov enot (M e.) (kar je enako 960 mikrogramom [µg]) filgrastima*.
Zarzio is not recommended during pregnancy. 
Zdravila Zarzio ne uporabljajte pri nosečnicah.
Cutaneous vasculitisa Sweets syndrome (acute febrile neutrophilic dermatosis) 
Bolezni kože in podkožja alopecijaa izpuščaja eritem makulopapularni izpuščaj kožni vaskulitisa Sweetov sindrom (akutna febrilna nevtrofilna dermatoza)
Neutropenia may be due to bone marrow-infiltrating opportunistic infections such as Mycobacterium avium complex or malignancies such as lymphoma. 
kompleksom Mycobacterium avium ali malignimi obolenji, npr. limfomi.
Unless your doctor directs you otherwise, you must stop breast feeding if you use Zarzio. 
Če uporabljate zdravilo Zarzio, morate prenehati z dojenjem, razen če vam zdravnik svetuje drugače.
Zarzio 30 MU/0.5 ml solution for injection or infusion in pre-filled syringe: Each pre-filled syringe contains 30 MU filgrastim in 0.5 ml, corresponding to 60 MU/ml. 
Zarzio 30 M e./0,5 ml raztopina za injiciranje ali infundiranje v napolnjeni injekcijski brizgi: Ena napolnjena injekcijska brizga vsebuje 30 milijonov enot filgrastima v 0,5 ml, kar ustreza 60 M e./ml.
Zarzio 30 MU/0.5 ml solution for injection or infusion in pre-filled syringe Each ml of solution contains 60 million units (MU) (equivalent to 600 micrograms [μg]) filgrastim*. 
Zarzio 30 M e./0,5 ml raztopina za injiciranje ali infundiranje v napolnjeni injekcijski brizgi En mililiter raztopine vsebuje 60 milijonov enot (M e.) (kar je enako 600 mikrogramom [µg]) filgrastima*.
How to store Zarzio 
Shranjevanje zdravila Zarzio
Zarzio is a biosimilar medicinal product. 
Zdravilo Zarzio je podobno biološko zdravilo.
• if you have any of the following or combination of the following side effects: swelling or puffiness, which may be associated with passing water less frequently, difficulty breathing, abdominal swelling and feeling of fullness, and a general feeling of tiredness. 
oteklost ali zabuhlost, ki jo lahko spremlja manj pogostejše odvajanje urina, težko dihanje,